New research suggests that Yasmin, a popular prescription contraceptive, carries a higher risk of blood clots. An independent study was conducted by researchers at the Leiden University Medical Center in the Netherlands. The results were published in the British Medical Journal during the summer of 2009.
The Leiden University study concluded that birth control pills containing the ingredient drospirenone – like Yasmin – are two times more likely to cause blood clots than other birth control pills, which generally contain levonorgestrel. Yet the alleged increased risk of blood clots from Yasmin side effects was not offset by effectiveness. Researchers discovered that all of the oral contraceptives involved in the study were equally effective in preventing pregnancy.
Yasmin is produced by Bayer Healthcare Pharmaceuticals. The use of “drospirenone,” a form of progestin unique to Bayer products, is not used in any other birth control pills available in the U.S. Drospirenone elevates blood potassium levels creating a condition known as hyperkalemia. Hyperkalemia can lead to heart problems and other health issues. Some of the health risks or side effects associated with Yasmin include: blood clots or deep vein thrombosis, heart attack, stroke, gallbladder disease, kidney damage or kidney disease, cardiac arrhythmias, and even sudden death.
Bayer Healthcare has been criticized for failure to disclose and provide adequate warning of potential health risks associated with Yasmin. Bayer is also under fire by consumers and medical professionals for allegedly making misleading statements and deceptive claims of superior benefits in its Yasmin advertisements.
A number of consumers in the US – victims of blood clots, heart attacks, strokes, and other illnesses – are filing Yasmin lawsuits against Bayer. They allege that Bayer‘s medical research and warnings of health risks have been inadequate. The consumer complaints also accuse Bayer of making its top priority profits instead of consumer safety.
In spite of growing concerns about the Yasmin health risks, Bayer continues to stand behind its popular birth control pills. Kermal Malik, M.D., Chief Medical Officer at Bayer, stated in a press release: “We are convinced that Yasmin is a good choice for women seeking convenient and reliable contraception if they use the product as directed.”
Nevertheless, Bayer is taking some steps to improve its public image. Bayer agreed last year, as part of a settlement with U.S. drug regulators and state attorneys from 27 states, to run a $20 million corrective advertising campaign. Bayer has also agreed to update its European label to include additional information on the risk of blood clots. Swissmedic, the medical agency of Switzerland, announced that Yasmin will remain for sale in its market, despite the risk of blood clots. Swissmedic added that even though there is higher risk with Yasmin, the risk remains “within reasonable limits.”
If you or a loved one has experienced a serious side effect or symptoms of side effects related to Yaz, Yasmin, or the generic Ocella, contact Newsome Law Firm and fill out a case evaluation form today. Our team of attorneys has experience specific to complications associated with prescription medication recalls. Not only can they give you the legal guidance you need, they can help you get the compensation you deserve.